McCormick, R., Blick, C., Ragoussis, J., Schoedel, J., Mole, D., Young, A., . . . Harris, A. (2013). miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.
Chicago-čujuhus (17. p.)McCormick, R., C. Blick, J. Ragoussis, J. Schoedel, D. Mole, A. Young, P. Selby, R. Banks, juo A. Harris. MiR-210 Is a Target of Hypoxia-inducible Factors 1 and 2 in Renal Cancer, Regulates ISCU and Correlates with Good Prognosis. 2013.
MLA-čujuhus (9. p.)McCormick, R., et al. MiR-210 Is a Target of Hypoxia-inducible Factors 1 and 2 in Renal Cancer, Regulates ISCU and Correlates with Good Prognosis. 2013.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.